Exosens Shares Jump 3.88% at Close, Regaining Momentum
The share price of French defense optronics specialist Exosens closed the session on Wednesday, December 3, 2025, up by 3.88%, settling at 44.15 euros compared to 42.50 euros the previous day. This increase is part of a supportive market environment, with the CAC 40 modestly up by 0.16% at 8,087.42 points. Trading volumes remained limited, with only 0.26% of the capital traded during the day.
Annual Performance and Market Dynamics
Over the past year, Exosens has shown a spectacular performance with an increase of 153.2%, significantly outperforming the CAC 40's 11.75% over the same period. The stock benefits from a confirmed medium-term upward trend: it has risen by 6.9% over the last week and 17.58% over the past three months. This positive streak follows a technical consolidation phase that began several sessions ago, with the stock having declined by 2.74% on Monday, December 1. Since its IPO in June 2024, the company has been riding a strong operational wave in the defense sector. Exosens announced at the end of October a robust revenue growth of 23.2% to 327.8 million euros over nine months, driven by the favorable dynamics of the final defense markets. The results are perfectly aligned with the targets set for 2025, with revenue growth expected at the upper end of the 15-20% range and adjusted EBITDA growth at the lower end of the 20-25% range.
Technical Analysis and Stock Performance
Technically, the stock is currently trading below its 50-day moving average of 45.27 euros, suggesting a period of consolidation after a strong bullish rally this year. The RSI, at 34, is in the oversold zone, which may indicate a potential for a short-term technical rebound if buyers step in. The price level of 44.15 euros positions the stock between its support at 41 euros and its resistance at 49.60 euros, leaving about a 12% margin for progression before reaching this psychological threshold. The 200-day moving average, at 39.75 euros, remains significantly below the current price, reflecting the strength of the underlying bullish trend since the IPO. The one-month volatility stands at 9.90%, reflecting the natural fluctuations of a growth stock in the defense sector. The negative beta of -0.07 confirms the stock's low correlation with the CAC 40, as Exosens moves according to its own sector dynamics.
Strategic Position and Future Outlook
Like other companies heavily exposed to the defense sector, Exosens has benefited from multiple announcements of increased military spending in Europe. As a global leader, the French group fully capitalizes on its strategic supplier position to NATO countries. The company highlights the strong dynamics of the Amplification segment, which represents the bulk of its activity, with additional investment in production capacities now expected to increase by 40% by 2027. Investors are closely monitoring the evolution of the group's order book, driven by ongoing geopolitical tensions and European rearmament.
